loadpatents
name:-0.016523122787476
name:-0.013170957565308
name:-0.00049495697021484
Azuma; Mitsuyoshi Patent Filings

Azuma; Mitsuyoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Azuma; Mitsuyoshi.The latest application filed is for "therapeutic agent for corneal epithelial disorder".

Company Profile
0.14.12
  • Azuma; Mitsuyoshi - Kobe JP
  • AZUMA; Mitsuyoshi - Kobe-shi Hyogo
  • Azuma; Mitsuyoshi - Hyogo N/A JP
  • Azuma; Mitsuyoshi - Nishinomiya-shi JP
  • Azuma; Mitsuyoshi - Nishinomiya JP
  • Azuma; Mitsuyoshi - Nishinomiya-shi Hyogo JP
  • Azuma; Mitsuyoshi - Amagasaki JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutic agent for corneal epithelial disorder
Grant 9,562,231 - Nakagawa , et al. February 7, 2
2017-02-07
Therapeutic Agent For Corneal Epithelial Disorder
App 20160208250 - NAKAGAWA; Ayumi ;   et al.
2016-07-21
Neurite formation promoter
Grant 8,637,544 - Yabuta , et al. January 28, 2
2014-01-28
Partial peptide of lacritin
Grant 8,518,412 - Nakajima , et al. August 27, 2
2013-08-27
Partial peptide of lacritin
Grant 8,383,130 - Nakajima , et al. February 26, 2
2013-02-26
Partial Peptide Of Lacritin
App 20120245102 - Nakajima; Takeshi ;   et al.
2012-09-27
Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitor
Grant 8,268,794 - Nakajima , et al. September 18, 2
2012-09-18
Pharmaceutical Containing Hif-1 Alpha And Hif-2 Alpha Expression Inhibitor
App 20110213008 - Nakajima; Takeshi ;   et al.
2011-09-01
Corneal Neuritogenesis Promoter Containing Pacap and Its Derivative
App 20110212899 - Takayama; Yoshiko ;   et al.
2011-09-01
Agent for repairing corneal sensitivity containing amide compound
Grant 7,956,072 - Takayama , et al. June 7, 2
2011-06-07
Partial Peptide Of Lacritin
App 20110008891 - Nakajima; Takeshi ;   et al.
2011-01-13
Cell Capable Of Expressing Lacritin At High Level
App 20100183572 - Nakajima; Takeshi ;   et al.
2010-07-22
Neurite Formation Promoter
App 20100144792 - Yabuta; Chiho ;   et al.
2010-06-10
Agent for repairing corneal sensitivity containing amide compound
App 20090118322 - Takayama; Yoshiko ;   et al.
2009-05-07
Corneal perception recovery drug containing amide compound
Grant 7,485,654 - Takayama , et al. February 3, 2
2009-02-03
Agent for repairing corneal perception
App 20070093513 - Takayama; Yoshiko ;   et al.
2007-04-26
Corneal perception recovery drug containing amide compound
App 20060252765 - Takayama; Yoshiko ;   et al.
2006-11-09
Remedy for corneal failure
App 20060234922 - Takayama; Yoshiko ;   et al.
2006-10-19
Preventives/remedies for glaucoma
Grant 6,673,812 - Azuma , et al. January 6, 2
2004-01-06
Agent for prophylaxis and treatment of glaucoma
Grant 6,649,625 - Azuma , et al. November 18, 2
2003-11-18
Agent for prophylaxis and treatment of glaucoma
App 20030125351 - Azuma, Mitsuyoshi ;   et al.
2003-07-03
Angiogenesis inhibitor
Grant 6,057,290 - Fukiage , et al. May 2, 2
2000-05-02
Therapeutic composition for diabetic complications
Grant 4,794,124 - Yamamoto , et al. December 27, 1
1988-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed